We are live on ! Find out more
Oracle Alpha

Oracle Alpha Portfolio holdings

AUM $55.7M Turnover 44.04%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$55.7M
AUM Growth
-$21.5M
Cap. Flow
-$24.9M
Cap. Flow %
-44.61%
Top 10 Hldgs %
13.49%
Holding
277
New
30
Increased
43
Reduced
112
Closed
92
Avg Time Held
0.2 years
Top 10 Avg Time Held
0.2 years
Top 20 Avg Time Held
0.2 years

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$778K
2
MRK icon
Merck
MRK
+$706K
3
CYTK icon
Cytokinetics
CYTK
+$518K
4
GIII icon
G-III Apparel Group
GIII
+$509K
5
TXN icon
Texas Instruments
TXN
+$462K

Sector Composition

Rank Sector Weight
1 Technology 26.05%
2 Healthcare 15.86%
3 Consumer Discretionary 15.01%
4 Financials 12.18%
5 Energy 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MU icon
1
Micron Technology
MU
$1T
$873K 1.57%
7,403
+3,755
+103% +$340K
2023 Q4
1 quarter
COIN icon
2
Coinbase
COIN
$38B
$855K 1.53%
3,226
-668
-17% -$120K
2023 Q4
1 quarter
LLY icon
3
Eli Lilly
LLY
$1.26T
$833K 1.49%
1,071
-489
-31% -$348K
2023 Q4
1 quarter
INTC icon
4
Intel
INTC
$350B
$830K 1.49%
18,788
-2,041
-10% -$90.9K
2023 Q4
1 quarter
NVDA icon
5
NVIDIA
NVDA
$4.94T
$807K 1.45%
8,930
-10,730
-55% -$778K
2023 Q4
1 quarter
M icon
6
Macy's
M
$6.3B
$753K 1.35%
37,656
+26,817
+247% +$518K
2023 Q4
1 quarter
IOT icon
7
Samsara
IOT
$24.6B
$689K 1.24%
18,230
-9,596
-34% -$326K
2023 Q4
1 quarter
AMAT icon
8
Applied Materials
AMAT
$310B
$672K 1.21%
3,257
+780
+31% +$143K
2023 Q4
1 quarter
SYF icon
9
Synchrony
SYF
$24.5B
$658K 1.18%
15,260
-3,410
-18% -$136K
2023 Q4
1 quarter
GTLB icon
10
GitLab
GTLB
$9.01B
$548K 0.98%
9,393
-6,028
-39% -$395K
2023 Q4
1 quarter
PTCT icon
11
PTC Therapeutics
PTCT
$5.01B
$546K 0.98%
18,755
+6,546
+54% +$183K
2023 Q4
1 quarter
NFLX icon
12
Netflix
NFLX
$258B
$536K 0.96%
8,830
+4,140
+88% +$233K
2023 Q4
1 quarter
JNJ icon
13
Johnson & Johnson
JNJ
$658B
$530K 0.95%
3,348
-1,020
-23% -$162K
2023 Q4
1 quarter
REGN icon
14
Regeneron Pharmaceuticals
REGN
$96B
$528K 0.95%
549
-144
-21% -$137K
2023 Q4
1 quarter
TMO icon
15
Thermo Fisher Scientific
TMO
$258B
$523K 0.94%
899
-714
-44% -$401K
2023 Q4
1 quarter
LIN icon
16
Linde
LIN
$236B
$512K 0.92%
1,103
-25
-2% -$10.8K
2023 Q4
1 quarter
DHR icon
17
Danaher
DHR
$163B
$509K 0.91%
2,038
+532
+35% +$130K
2023 Q4
1 quarter
SNOW icon
18
Snowflake
SNOW
$108B
$498K 0.89%
3,084
-1,157
-27% -$224K
2023 Q4
1 quarter
PCOR icon
19
Procore
PCOR
$9.33B
$494K 0.89%
6,018
-3,759
-38% -$279K
2023 Q4
1 quarter
HCP icon
20
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$490K 0.88%
18,171
+2,414
+15% +$58.5K
2023 Q4
1 quarter
TSLA icon
21
Tesla
TSLA
$1.58T
$485K 0.87%
2,760
-247
-8% -$48.3K
2023 Q4
1 quarter
BHF icon
22
Brighthouse Financial
BHF
$2.53B
$480K 0.86%
9,305
-2,860
-24% -$142K
2023 Q4
1 quarter
VRTX icon
23
Vertex Pharmaceuticals
VRTX
$142B
$479K 0.86%
1,147
+277
+32% +$117K
2023 Q4
1 quarter
BFH icon
24
Bread Financial
BFH
$3.93B
$475K 0.85%
12,750
+5,210
+69% +$185K
2023 Q4
1 quarter
RIVN icon
25
Rivian
RIVN
$17.7B
$470K 0.84%
42,950
+16,526
+63% +$238K
2023 Q4
1 quarter

Similar funds

Oracle Alpha's Q1 2024 Portfolio in Review

As of Q1 2024, Oracle Alpha held 277 positions worth $55.7M, down 28% from $77.3M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Oracle Alpha withdrew a net $24.9M in Q1 2024, closing 92 positions and reducing 112 holdings. Its most notable exit was Merck, an estimated $706K position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Oracle Alpha opened a new position in Victoria's Secret worth $291K.

  • Oracle Alpha's largest Q1 2024 buy was Victoria's Secret: 14,995 shares worth $291K.
  • Oracle Alpha added most to Macy's in Q1 2024, an estimated $518K increase.
  • Oracle Alpha's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $778K.
  • Oracle Alpha fully exited Merck in Q1 2024, selling an estimated $706K.
  • Oracle Alpha's ten largest holdings make up 13% of its $55.7M portfolio in Q1 2024.
  • Oracle Alpha opened 30 new positions and closed 92 in Q1 2024.
  • Oracle Alpha's portfolio value fell 28% quarter-over-quarter to $55.7M.

Based on Oracle Alpha's 13F filing for Q1 2024, filed 15 May 2024.